Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial) - Scorecard - MDSpire
Clinical Scorecard: Safety and effectiveness of the ranibizumab port delivery system for diabetic macular oedema: the PAGODA randomized clinical trial
At a Glance
Category
Detail
Condition
Not specified in the supplied context.
Key Mechanisms
Not specified in the supplied context.
Target Population
Not specified in the supplied context.
Care Setting
Not specified in the supplied context.
Key Highlights
Malhotra et al. presented the Pagoda study results at the Association for Research in Vision and Ophthalmology meeting in Seattle, Washington, May 5–9, 2024.
Khanani et al. subsequently published the results.
